Follow
James Korkola
James Korkola
Verified email at ohsu.edu - Homepage
Title
Cited by
Cited by
Year
Subtype and pathway specific responses to anticancer compounds in breast cancer
LM Heiser, A Sadanandam, WL Kuo, SC Benz, TC Goldstein, S Ng, ...
Proceedings of the National Academy of Sciences 109 (8), 2724-2729, 2012
5362012
The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations
AB Keenan, SL Jenkins, KM Jagodnik, S Koplev, E He, D Torre, Z Wang, ...
Cell systems 6 (1), 13-24, 2018
3882018
Bladder cancer outcome and subtype classification by gene expression
E Blaveri, JP Simko, JE Korkola, JL Brewer, F Baehner, K Mehta, ...
Clinical Cancer Research 11 (11), 4044-4055, 2005
3712005
Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13. 31, is associated with in vivo differentiation of human male germ cell tumors
JE Korkola, J Houldsworth, RSV Chadalavada, AB Olshen, D Dobrzynski, ...
Cancer research 66 (2), 820-827, 2006
3422006
A central role for RAF→ MEK→ ERK signaling in the genesis of pancreatic ductal adenocarcinoma
EA Collisson, CL Trejo, JM Silva, S Gu, JE Korkola, LM Heiser, ...
Cancer discovery 2 (8), 685-693, 2012
3322012
Modeling precision treatment of breast cancer
A Daemen, OL Griffith, LM Heiser, NJ Wang, OM Enache, Z Sanborn, ...
Genome biology 14, 1-14, 2013
3282013
Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors
JA Veltman, J Fridlyand, S Pejavar, AB Olshen, JE Korkola, S DeVries, ...
Cancer research 63 (11), 2872-2880, 2003
3102003
Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis
JE Korkola, S DeVries, J Fridlyand, ES Hwang, ALH Estep, YY Chen, ...
Cancer research 63 (21), 7167-7175, 2003
2792003
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival
CE Gast, AD Silk, L Zarour, L Riegler, JG Burkhart, KT Gustafson, ...
Science advances 4 (9), eaat7828, 2018
2282018
Modeling tumor phenotypes in vitro with three-dimensional bioprinting
EM Langer, BL Allen-Petersen, SM King, ND Kendsersky, MA Turnidge, ...
Cell reports 26 (3), 608-623. e6, 2019
1992019
Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma
E Shelley Hwang, SJ Nyante, Y Yi Chen, D Moore, S DeVries, JE Korkola, ...
Cancer 100 (12), 2562-2572, 2004
1992004
Exome sequencing of cell-free DNA from metastatic cancer patients identifies clinically actionable mutations distinct from primary disease
TM Butler, K Johnson-Camacho, M Peto, NJ Wang, TA Macey, JE Korkola, ...
PloS one 10 (8), e0136407, 2015
1322015
A multi-center study on the reproducibility of drug-response assays in mammalian cell lines
M Niepel, M Hafner, CE Mills, K Subramanian, EH Williams, M Chung, ...
Cell systems 9 (1), 35-48. e5, 2019
1212019
CCR5 governs DNA damage repair and breast cancer stem cell expansion
X Jiao, MA Velasco-Velazquez, M Wang, Z Li, H Rui, AR Peck, JE Korkola, ...
Cancer research 78 (7), 1657-1671, 2018
1202018
A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells
EP Papapetrou, JE Korkola, M Sadelain
Stem cells 28 (2), 287-296, 2010
1052010
Breast cancer genomes—form and function
J Korkola, JW Gray
Current opinion in genetics & development 20 (1), 4-14, 2010
952010
Cellular senescence in cancer: from mechanisms to detection
HL Ou, R Hoffmann, C González‐López, GJ Doherty, JE Korkola, ...
Molecular Oncology 15 (10), 2634-2671, 2021
902021
Biology and genetics of adult male germ cell tumors
J Houldsworth, JE Korkola, GJ Bosl, RSK Chaganti
Journal of clinical oncology 24 (35), 5512-5518, 2006
902006
Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors
JE Korkola, J Houldsworth, DR Feldman, AB Olshen, LX Qin, S Patil, ...
Journal of clinical oncology 27 (31), 5240, 2009
892009
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
A Daemen, DM Wolf, JE Korkola, OL Griffith, JR Frankum, R Brough, ...
Breast cancer research and treatment 135, 505-517, 2012
862012
The system can't perform the operation now. Try again later.
Articles 1–20